Status:

RECRUITING

Aspects of Self-harm - Cognition, Imaging and Treatability

Lead Sponsor:

Region Skane

Collaborating Sponsors:

Lund University

Conditions:

Self-Harm, Deliberate

Non-Suicidal Self Injury

Eligibility:

All Genders

18-65 years

Brief Summary

Deliberate self-harm (DSH) is a common symptom in psychiatric disorders. This study aim at increased understanding of parameters associated with DSH with the long term goal to potentially improve and ...

Detailed Description

Deliberate self-harm (DSH) is a common symptom in psychiatric disorders. Today, there is not sufficient knowledge as to why an individual continues to suffer from DSH, DSH is reduced or even ceased - ...

Eligibility Criteria

Inclusion

  • Inclusion criteria for persistent DSH group:
  • Adults 18-65 years.
  • Ability to leave informed consent.
  • Understands and uses the Swedish language without significant difficulties.
  • Psychiatric disorder and ongoing treatment at an adult psychiatric clinic.
  • DSH at least five times during the last three months, and DSH at least ten times during at least one year.
  • Exclusion criteria for persistent DSH group:
  • No history of DSH, and/or DSH fewer than five times during the last three months and fewer than ten times during at least one year
  • Diagnosis of Intellectual disability
  • Diagnosis of chronic psychotic disorder
  • Hearing disability, visual impairment or motor disorder that rules out the ability to complete neurocognitive tasks
  • Inclusion criteria for those who have ceased DSH group:
  • Adults 18-65 years.
  • Ability to leave informed consent.
  • Understands and uses the Swedish language without significant difficulties.
  • Psychiatric disorder and ongoing treatment at an adult psychiatric clinic.
  • No DSH during the last three months, but DSH at least ten times during at least one year.
  • Exclusion criteria for those who have ceased DSH group:
  • Any DSH during the last three months, and/or fewer than ten times during the at least one year
  • Diagnosis of Intellectual disability
  • Diagnosis of chronic psychotic disorder
  • Hearing disability, visual impairment or motor disorder that rules out the ability to complete neurocognitive tasks
  • Inclusion criteria for psychiatric disorder with no history of DSH group:
  • Adults 18-65 years.
  • Ability to leave informed consent.
  • Understands and uses the Swedish language without significant difficulties.
  • Psychiatric disorder and ongoing treatment at an adult psychiatric clinic.
  • Exclusion criteria for psychiatric disorder with no history of DSH group:
  • Any DSH during the last three months, and more than two times during lifetime
  • Diagnosis of Intellectual disability
  • Diagnosis of chronic psychotic disorder
  • Hearing disability, visual impairment or motor disorder that rules out the ability to complete neurocognitive tasks
  • Inclusion criteria for healthy control group:
  • Adults 18-65 years.
  • Ability to leave informed consent.
  • Understands and uses the Swedish language without significant difficulties.
  • Exclusion criteria for healthy control group:
  • Diagnosed with any psychiatric disorder
  • Any DSH during the last three months, and more than two times during lifetime
  • Hearing disability, visual impairment or motor disorder that rules out the ability to complete neurocognitive tasks

Exclusion

    Key Trial Info

    Start Date :

    April 30 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2025

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT04905797

    Start Date

    April 30 2021

    End Date

    December 31 2025

    Last Update

    August 6 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Psykiatri och habilitering, Region Skåne

    Lund, Skåne County, Sweden, 22185